Addressing Clinical Trial Diversity: Challenges, Opportunities, and Critical Capabilities
The 2024 SCOPE Europe conference featured a presentation on clinical trial diversity, highlighting the critical need for diversity and...
Roche Innovative Approach to Data-Driven Site Selection in Clinical Trials
In a groundbreaking presentation at SCOPE Europe 2024, Susannah Finney, Clinical Operations Lead and Product Owner at Roche, UK,...
AI and ML in Drug Development – A Deep Dive at DPHARM
The DPHARM conference brought together a panel of experts to discuss the transformative potential of Artificial Intelligence (AI) and...
Novartis Presents New Clinical Trial ALS Digital Health Biomarkers
At Panagora’s 7th Annual Digital Biomarkers in Clinical Trials Summit, Novartis presented a groundbreaking study on digital home-based assessments...
AI in Biopharmaceutical R&D: From Theory to Practice
At a recent conference, industry leaders gathered to explore the transformative potential of artificial intelligence (AI) in clinical trials,...
How High Interest Rates Are Impacting Clinical Trial Investment
The DPHARM 2024 conference recently convened a panel of industry leaders to discuss the alignment of innovations to address...
DPHARM Follow the Money: Investor Insights on Technology Investment in Clinical Trials
The DPHARM conference brought together a distinguished panel to discuss the critical role of technology investment in clinical trials....
How Johnson & Johnson is Innovating its Organizational Infrastructure
At DPHARM 2024, Johnson & Johnson’s representatives, Gordon Gregory III, and Laszlo Vasko, unveiled their transformative “Team of Teams”...
How To Measure ROI in Decentralized Clinical Trials
At the 2024 DPHARM conference, Ken Getz, Executive Director and Research Professor at Tufts Center for the Study of...
Navigating Clinical Research Technology As a Study Site
In this interview, we sit down with Alisha Garibaldi, CEO of Skylight Health Research, to discuss managing clinical research...